Hulim Robot Shares Rise to 5,250 Won... Subsidiary EQcell Wins 9.3 Billion Won Order for Perovskite Solar Cell Equipment
Hulim Robot's share price is on the rise, helped by news that its subsidiary EQcell has won an order for solar cell equipment. On the morning of the 22nd, Hulim Robot's stock price stood at 5,250 won, up 30 won (about 0.57%) from the previous trading day. This represents a slight increase from the

Hulim Robot's share price is on the rise, helped by news that its subsidiary EQcell has won an order for solar cell equipment.
On the morning of the 22nd, Hulim Robot's stock price stood at 5,250 won, up 30 won (about 0.57%) from the previous trading day. This represents a slight increase from the previous day's closing price of 5,220 won.
◆ EQcell Wins 9.3 Billion Won Order for Perovskite Solar Cell Equipment from Company C
According to media reports on the 20th, Hulim Robot's subsidiary EQcell announced that it had received an order for mass-production equipment for perovskite solar cells worth approximately 7 million dollars (about 9.3 billion won) from Company C, a global battery and energy company.
This order is notable in that it is a contract for EQcell to supply solar cell-related equipment. Perovskite solar cells are one of the next-generation solar cell technologies, and attention is also focused on the business trends of companies supplying related production equipment.
◆ Delivery Schedule and Revenue Recognition Timing Require Separate Confirmation
However, the specific delivery schedule, timing of revenue recognition, and profitability of this contract need to be confirmed separately. The impact of the contract on Hulim Robot's consolidated results may also vary depending on the actual execution of the contract and accounting treatment.
Although Hulim Robot's share price rose to 5,250 won on this day, it has not been confirmed whether the subsidiary's order news was the direct cause of the stock price increase.
[This article is intended to provide information for investment reference and does not recommend the purchase or sale of any specific stock. Content may vary depending on market conditions. Investment decisions and the responsibility for them rest with the investor. AI provided partial assistance.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.

![[Breaking] Critical PHP Security Vulnerability Discovered... MSIT and KISA Urge Domestic Companies to Take Urgent Security Measures](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F08%2F595825%2F727d25f9475586e1%2Fvariants%2Fhero.webp&w=1920&q=75)

![[Breaking] Celltrion Signs License-in Deal Worth Up to 769.5 Billion Won with U.S. Kaigene for Anti-APRIL Antibody 'KG013'](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F583068%2Fd06e9858d8dc15e0%2Fvariants%2Fhero.webp&w=1920&q=75)